Patents by Inventor Marti CABANES-CREUS

Marti CABANES-CREUS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067678
    Abstract: The present disclosure relates generally to adeno-associated vims (AAV) capsid polypeptides and encoding nucleic acid molecules. The disclosure also relates to AAV vectors comprising the capsid polypeptides, and nucleic acid vectors (e.g. plasmids) comprising the encoding nucleic acids molecules, as well as to host cells comprising the vectors. The disclosure also relates to methods and uses of the polypeptides, encoding nucleic acids molecules, vectors and host cells. The disclosure includes AAV capsid polypeptides comprising a peptide modification in variable region 8 (VR VIII), where the peptide modification comprises a 7 amino acid insertion.
    Type: Application
    Filed: December 16, 2021
    Publication date: February 29, 2024
    Applicant: Children's Medical Research Institute
    Inventors: Adrian WESTHAUS, Leszek LISOWSKI, Marti CABANES CREUS
  • Publication number: 20230093183
    Abstract: The present disclosure relates generally to adeno-associated virus (AAV) capsid polypeptides and encoding nucleic acid molecules. The disclosure also relates to AAV vectors comprising the capsid polypeptides, and nucleic acid vectors (e.g. plasmids) comprising the encoding nucleic acids molecules, as well as to host cells comprising the vectors. The disclosure also relates to methods and uses of the polypeptides, encoding nucleic acids molecules, vectors and host cells.
    Type: Application
    Filed: February 25, 2021
    Publication date: March 23, 2023
    Inventors: Leszek Lisowski, Marti Cabanes Creus, Ian Alexander, Matthias Charles Jerome Hebben
  • Publication number: 20220372512
    Abstract: The present disclosure relates generally to methods and adeno-associated virus (AAV) vectors for in vivo transduction. The disclosure is directed to methods for producing modified AAV capsid polypeptides and AAV vectors that are suitable for transduction of cells in vivo, and methods for screening AAV vectors. The disclosure also relates to adeno-associated virus (AAV) capsid polypeptides and encoding nucleic acid molecules, AAV vectors comprising the capsid polypeptides, and nucleic acid vectors comprising the encoding nucleic acids molecules, as well as to host cells comprising the vectors. The disclosure also relates to methods and uses of the polypeptides, encoding nucleic acids molecules, vectors and host cells.
    Type: Application
    Filed: July 3, 2020
    Publication date: November 24, 2022
    Inventors: Leszek LISOWSKI, Ian Edward ALEXANDER, Marti CABANES CREUS, Claus Volker HALLWIRTH, Samantha Lee GINN
  • Publication number: 20210388343
    Abstract: The present disclosure relates generally to nucleic acid molecules and methods for identifying AAV vectors with desirable properties, including nucleic acid molecules and methods useful for identifying novel cap genes for vectorization, production of AAV vectors and AAV libraries.
    Type: Application
    Filed: October 17, 2019
    Publication date: December 16, 2021
    Applicant: Children's Medical Research Institute
    Inventors: Leszek LISOWSKI, Marti CABANES-CREUS, Adrian WESTHAUS